The enhanced partnership promises to deliver a host of additional first-in-class products and solutions to the plant research and development community in commercial, as well as, nonprofit foundations, consortia, and academic institutions.
With a potential deal value exceeding $1 million, the multiyear partnership leverages the core expertise and experience of each company to deliver cutting-edge, robust and comprehensive products for customers. Arbor Biosciences brings decades of combined expertise in NGS with novel advanced synthesis chemistry and expert scientific consulting to develop both catalog and custom targeted sequencing panels. Curio Genomics brings decades of experience in big-data commercial software platforms designed from the beginning for limitless scalability and extensibility, essential for genomic research with larger data sets, new types, and greater demand to integrative analyses each year.
“This is a transformative partnership for Curio,” said David Brabec, Curio’s Chief Business Officer. “We know that researchers, both commercial and academic, want and ...
